Wells Fargo Keeps Amrize at Equal-Weight, Cuts Target to $39
Wells Fargo maintained its Equal-Weight rating on Amrize and lowered its price target to $39 from $40.
Wells Fargo maintained its Equal-Weight rating on Amrize and lowered its price target to $39 from $40.